The investment arm of one of the world’s biggest insurers just made major changes in its U.S.-traded investments, selling off 2024 winners and buying up a laggard. MEAG Munich Ergo Asset ...

The S&P 500 edged 0.4% higher on Thursday, Feb. 6, as investors responded to the latest earnings results and awaited Friday ...

Philip Morris continues to see solid growth led by Zyn. It has a big opportunity in a few years with its IQOS product in the U.S. The stock is attractively valued and still has a nice dividend yield.

Investors with a lot of money to spend have taken a bullish stance on Philip Morris Intl (NYSE:PM). And retail traders should know. We noticed this today when the positions showed up on publicly ...

Tobacco seller Philip Morris International (PM) recently soared to new heights on the back of its blockbuster Q4 2024 earnings results, thereby throwing its hat into the ring as a titan value and ...

Overall, the quarter highlighted Philip Morris's strategic shift towards smoke-free products, supporting a strong financial performance despite lingering reliance on traditional tobacco products.

Whales with a lot of money to spend have taken a noticeably bullish stance on Philip Morris Intl. Looking at options history for Philip Morris Intl PM we detected 42 trades. If we consider the ...

Philip Morris posts Q4 revenue growth of 7.3% to $9.71 billion. Philip Morris expects FY25 adjusted EPS of $7.04 - $7.17. Get real-time earnings alerts before the market moves and access expert ...

Shares of Philip Morris International are on track for an all-time closing high, after the company reported strong sales growth for its Marlboro cigarettes and Zyn nicotine pouches. The tobacco ...

Philip Morris International Inc. (PM), a tobacco company, on Thursday reported fourth quarter net loss of $0.38 per share, compared ...

Looking ahead, Philip Morris guided for organic revenue to grow by between 6% to 8%, with volume growth of around 2%. It expects smoke-free volumes to increase by between 12% to 14%.